Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Daniel Starks, CEO of St. Jude Medical, says the company has been overly optimistic about the shrinking cardiac rhythm management market.
Medtronic launches a study comparing its CoreValve heart valve with traditional open heart surgery, saying the 2,500-patient trial will be the largest TAVI investigation to date.
Republican lawmakers in Massachusetts urge Democratic Senate candidate Elizabeth Warren to take a stronger stand against the looming medical device tax.